Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

Kalari S, Jung M, Kernstine KH, Takahashi T, Pfeifer GP.

Oncogene. 2013 Jul 25;32(30):3559-68. doi: 10.1038/onc.2012.362. Epub 2012 Aug 20.

2.

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S.

Lung Cancer. 2012 Apr;76(1):32-8. doi: 10.1016/j.lungcan.2011.10.002. Epub 2011 Nov 1.

3.

Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells.

Kay P, Schlossmacher G, Matthews L, Sommer P, Singh D, White A, Ray D.

PLoS One. 2011;6(10):e24839. doi: 10.1371/journal.pone.0024839. Epub 2011 Oct 3. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/4aad3313-abac-404f-85b0-3b95aec89be4.

4.

Epigenetic inactivation of laminin-5-encoding genes in lung cancers.

Sathyanarayana UG, Toyooka S, Padar A, Takahashi T, Brambilla E, Minna JD, Gazdar AF.

Clin Cancer Res. 2003 Jul;9(7):2665-72.

5.

Loss of YAP1 defines neuroendocrine differentiation of lung tumors.

Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y.

Cancer Sci. 2016 Oct;107(10):1527-1538. doi: 10.1111/cas.13013. Epub 2016 Sep 9.

6.

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Voortman J, Lee JH, Killian JK, Suuriniemi M, Wang Y, Lucchi M, Smith WI Jr, Meltzer P, Wang Y, Giaccone G.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13040-5. doi: 10.1073/pnas.1008132107. Epub 2010 Jul 6.

7.

YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.

Horie M, Saito A, Ohshima M, Suzuki HI, Nagase T.

Cancer Sci. 2016 Dec;107(12):1755-1766. doi: 10.1111/cas.13078. Epub 2016 Nov 25.

8.

Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.

Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, Müllauer L, Dekan G, Grin Y, Lang G, End-Pfützenreuter A, Steiner I, Zehetmayer S, Döme B, Arns BM, Fong KM, Wright CM, Yang IA, Klepetko W, Posch M, Zielinski CC, Zöchbauer-Müller S.

Carcinogenesis. 2013 Mar;34(3):513-21. doi: 10.1093/carcin/bgs363. Epub 2012 Nov 19.

PMID:
23172663
9.

Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.

Yazawa T, Sato H, Shimoyamada H, Okudela K, Woo T, Tajiri M, Ogura T, Ogawa N, Suzuki T, Mitsui H, Ishii J, Miyata C, Sakaeda M, Goto K, Kashiwagi K, Masuda M, Takahashi T, Kitamura H.

Am J Pathol. 2009 Sep;175(3):976-87. doi: 10.2353/ajpath.2009.081004. Epub 2009 Aug 13.

10.

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.

Meredith SL, Bryant JL, Babur M, Riddell PW, Behrouzi R, Williams KJ, White A.

PLoS One. 2016 Feb 5;11(2):e0148404. doi: 10.1371/journal.pone.0148404. eCollection 2016.

11.

Lung tumours with neuroendocrine differentiation.

Travis WD.

Eur J Cancer. 2009 Sep;45 Suppl 1:251-66. doi: 10.1016/S0959-8049(09)70040-1. Review. No abstract available.

PMID:
19775623
12.

Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.

Ishii J, Sato H, Yazawa T, Shishido-Hara Y, Hiramatsu C, Nakatani Y, Kamma H.

Pathol Int. 2014 Sep;64(9):415-22. doi: 10.1111/pin.12198.

PMID:
25243889
13.

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.

Augustyn A, Borromeo M, Wang T, Fujimoto J, Shao C, Dospoy PD, Lee V, Tan C, Sullivan JP, Larsen JE, Girard L, Behrens C, Wistuba II, Xie Y, Cobb MH, Gazdar AF, Johnson JE, Minna JD.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93. doi: 10.1073/pnas.1410419111. Epub 2014 Sep 29.

14.

Differential inactivation of caspase-8 in lung cancers.

Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT, Reddy JL, Brambilla E, Takahashi T, Minna JD, Chaudhary PM, Gazdar AF.

Cancer Biol Ther. 2002 Jan-Feb;1(1):65-9.

PMID:
12170765
15.

Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.

Krohn A, Ahrens T, Yalcin A, Plönes T, Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, Claus R, Hackanson B, Burger M.

PLoS One. 2014 Jun 24;9(6):e100249. doi: 10.1371/journal.pone.0100249. eCollection 2014.

16.

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.

Heller G, Fong KM, Girard L, Seidl S, End-Pfützenreuter A, Lang G, Gazdar AF, Minna JD, Zielinski CC, Zöchbauer-Müller S.

Oncogene. 2006 Feb 9;25(6):959-68.

PMID:
16205641
17.

Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors.

Shimakage M, Kodama K, Kawahara K, Kim CJ, Ikeda Y, Yutsudo M, Inoue H.

Oncol Rep. 2009 Jun;21(6):1367-72.

PMID:
19424611
18.

Molecular genetics of small cell lung carcinoma.

Wistuba II, Gazdar AF, Minna JD.

Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Review.

PMID:
11479891
19.

Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumors.

Voortman J, Harada T, Chang RP, Killian JK, Suuriniemi M, Smith WI, Meltzer PS, Lucchi M, Wang Y, Giaccone G.

Curr Pharm Des. 2013;19(5):833-40.

PMID:
22973954
20.

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.

Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.

Clin Cancer Res. 2001 Jul;7(7):1998-2004.

Supplemental Content

Support Center